u/katrin_girard

My fasting insulin moved and it turned out to have nothing to do with glucose at all.

Research-use-only material is not approved for human use. In this board that is not a formality — it is the reason the clinical evidence base is as thin as it is.

stability in solution is the practical question nobody asks

Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board.

read the actual papers, they are more modest than the summaries

preclinical enthusiasm is not clinical evidence

Right, and net peptide content is where the counterion and the water go.

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

This. Area percent answers "what fraction of what the detector saw was the peak I wanted", and people read it as "how much peptide is in the vial".

This. Area percent answers "what fraction of what the detector saw was the peak I wanted", and people read it as "how much peptide is in the vial".

It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.

Disagree — that is a rodent study and you are stating it as a human effect. The distance between those is the entire argument.

Not quite. Two labs with different gradients can resolve a close-eluting impurity differently and both be reporting honestly.

identity and quantity are two questions and most documents answer one

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

UV at 214nm sees the peptide bond and picks up almost everything; at 280nm you are looking at aromatics only. Which wavelength the number came from is part of the number.

Correction: that is net peptide content, not purity. Different number, different meaning, and the document says so if you read the row label.

handling and storage vary enormously across this catalogue

Sent one vial to PeptideMeter and Medutest. 99.2% and a claimed 99.0%. Cost me more than the vial and I would do it again.

That result is an area percent from an unspecified method, which is not the same as the identity confirmation being discussed.

This. Area percent answers "what fraction of what the detector saw was the peak I wanted", and people read it as "how much peptide is in the vial".

a total of 0.4% tells you less than four named impurities adding to 0.6%

Agreed — identity first for anything off the well-travelled list. The purity number is meaningless until you know what it is pure of.

LC-MS gives you identity; UV purity gives you a relative quantity. A document with the first and not the second, or the reverse, is answering half the question.

Did you get the chromatogram or only the summary line?

Agreed, and the practical version is: ask for the itemised table. If it exists, you get it.

Not convinced. A high purity figure with no identity confirmation tells you the sample is homogeneous, not that it is what you ordered.

the counterion is part of the mass you paid for

Variability dropped before the average did, which was visible on the sensor and invisible on the lab result.

a1c can be affected by things that have nothing to do with glucose

UV at 214nm sees the peptide bond and picks up almost everything; at 280nm you are looking at aromatics only. Which wavelength the number came from is part of the number.

LC-MS gives you identity; UV purity gives you a relative quantity. A document with the first and not the second, or the reverse, is answering half the question.

It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.

redact your own name, never the batch details

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

Postprandial excursions typically respond earlier than fasting glucose, so the sequence people observe is not a sign that something is not working.

Yes. Nothing in this catalogue is approved for human use and the board should keep saying so.

Yes. Naming conventions in this corner are loose enough that the same word covers several different molecules.

What does the method line actually say? Not the technique — the column and the gradient.

Started keeping a folder of every certificate I have been sent. The ones that itemise impurities are a small group and they are mostly the same suppliers.

Agreed — the itemised related substances table is the difference between a document and a receipt.

Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rather than its size.

Same. The first day of a new sensor is unreliable and people rebuild their whole week around it.

What does time in range look like, not just the average?